國立臺灣大學 |
2008-03 |
Interleaving Phase Shifters for Critical-Mode Boost PFC
|
Tsai, J.-R.; Wu, T.-F.; Wu, C.-Y.; Lee, M.-C.; Chen, Y.-M. |
臺大學術典藏 |
2018-09-10T07:03:53Z |
Interleaving phase shifters for critical-mode boost PFC
|
Tsai, J.-R.; Wu, T.-F.; Wu, C.-Y.; Chen, Y.-M.; Lee, M.-C.; YAOW-MING CHEN |
大葉大學 |
2000-08 |
Interleaving Schemes for a Systolic RSA Public-Key Cryptosystem Based on an Improved Montgomery’s Algorithm
|
蔡培元;吳誠文 |
中國醫藥大學 |
2004 |
Interleukin (IL)-1 beta, IL-1 receptor antagonist, IL-6, IL-8, IL-10 and tumor necrosis factor alpha gene polymorphisms in patients with febrille seizures
|
Chou, IC; Tsai, CH; Lee, CC; Li, TC; Tsai, FJ; Yeh, TF |
中國醫藥大學 |
2010-05 |
Interleukin (IL)-1 β, IL-1 Receptor Antagonist, IL-6, IL-8, IL-10 and Tumor Necrosis Factor α Gene Polymorphisms in Patients with Febrile Seizures.
|
周宜卿(I-Ching Chou); 林瑋德(Wei-De Lin); 王仲興(Chung-Hsing Wang); 蔡長海(Chang-Hai Tsai); 李采娟(Tsai-Chung Li); 蔡輔仁(Fuu-Jen Tsai)* |
國立交通大學 |
2014-12-08T15:14:19Z |
Interleukin (IL)-12 receptor beta 1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3 '-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
Hsieh, Yao-Yuan; Chang, Chi-Chen; Tsai, Chang-Hai; Lin, Cheng-Chieh; Tsai, Fuu-Jen |
亞洲大學 |
2007-04 |
Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
Hsieh Yao-Yuan;Chi-Chen Chang;Chang-Hai Tsai;Lin,Cheng-Chieh;Tsai,Fuu-Jen |
中國醫藥大學 |
2007-04 |
Interleukin (IL)-12 receptor β1 codon 378 G homozygote and allele, but not IL-1 (β-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3′-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
|
謝耀元; (Chi-Chen Chang); 蔡長海; 林正介(Lin,Cheng-Chieh); 蔡輔仁(Tsai,Fuu-Jen)* |
大葉大學 |
2013-03 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;CH, Yeh;So, Edmund;Wang, Li-Yun;We, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
臺北醫學大學 |
2013 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping;Yeh, Ching-Hua;So, Edmund;Wang, Li-Yun;Wei, Tsui-Shan;Chang, Ming-Shi;Hsing, Chung-Hsi |
國立成功大學 |
2013-06 |
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression
|
Sun, Ding-Ping; Yeh, Ching-Hua; So, Edmund; Wang, Li-Yun; Wei, Tsui-Shan; Chang, Ming-Shi; Hsing, Chung-Hsi |
元培科技大學 |
2007 |
Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast like synoviocytes with rheumatoid arthritis via active nuclear factor kappaB and AP-1 dependent pathway
|
Fei-Lan Liu;Jiun-Han Chen; Deh-Ming Chang |
元培科技大學 |
2007 |
Interleukin (IL)-23 p19 expression induced by IL-1b in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-iB and AP-1 dependent pathway
|
F-L Liu;C.-H. Chen;S.-J. Ch;J.-H. Chen; J.-H. Lai; H.-K. Sytwu; D.-M. Chang |
臺北醫學大學 |
2014 |
Interleukin 10 and clustering of metabolic syndrome components in pediatrics
|
JS, Chang;CH, Bai;ZC, Huang;Owaga, E;KC, Chao;CC, Chang;HY, Chiou |
高雄醫學大學 |
2006 |
Interleukin 12 A1188C frequency of gastric ulcer patients in Taiwan
|
鄭宇辰;吳登強;吳宜珍;溫政浩;張學偉 |
國立臺灣大學 |
1990 |
Interleukin 2 and Lymphokine Activated Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma-a Preliminary Report
|
謝貴雄; Chang, J. S.; 吳慧琳; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, Hui-Lin; Chu, C. T. |
國立臺灣大學 |
1987 |
Interleukin 2 and Lymphokine-Activated Killer Cells in the Treatment of Childhood Primary Hepatocellular Carcinoma:A Preliminary Report
|
謝貴雄; Chang, J. S.; Wu, H. L.; Chu, C. T.; Hsieh, Kue-Hsiung; Chang, J. S.; Wu, H. L.; Chu, C. T. |
國立臺灣大學 |
1991 |
Interleukin 2 Therapy in Severe Atopic Dermatitis
|
謝貴雄; Chou, C. C.; Hsieh, Kue-Hsiung; Chou, C. C. |
臺大學術典藏 |
2021-08-19T10:23:39Z |
Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5 + Stem Cells via Inhibition of Wnt and Notch Signaling
|
Zha J.-M.; Li H.-S.; Lin Q.; WEI-TING KUO; Jiang Z.-H.; Tsai P.-Y.; Ding N.; Wu J.; Xu S.-F.; Wang Y.-T.; Pan J.; Zhou X.-M.; Chen K.; Tao M.; Odenwald M.A.; Tamura A.; Tsukita S.; Turner J.R.; He W.-Q. |
臺大學術典藏 |
2018-09-10T18:05:30Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Chin-Chung Shu and Jann-Yuan Wang and Ming-Fang Wu and Hsin-Chih Lai and Bor-Luen Chiang and Chong-Jen Yu; CHIN-CHUNG SHU; JANN-YUAN WANG |
臺大學術典藏 |
2020-07-03T04:00:29Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.;Wang J.-Y.;Wu M.-F.;Hsin-Chih Lai;Chiang B.-L.;Yu C.-J.; Shu C.-C.; Wang J.-Y.; Wu M.-F.; HSIN-CHIH LAI; Chiang B.-L.; Yu C.-J. |
臺大學術典藏 |
2021-06-29T08:39:13Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
CHIN-CHUNG SHU; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; Yu C.-J. |
臺大學術典藏 |
2022-06-27T07:00:01Z |
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; Lai H.-C.; Chiang B.-L.; CHONG-JEN YU |